Related Experiment Video
Updated: Apr 14, 2026

Sequencing of Bacterial Microflora in Peripheral Blood: our Experience with HIV-infected Patients
Published on: June 11, 2011
Gut microbiota trajectory in pediatric patients undergoing hematopoietic SCT
1Department of Pharmacy and Biotechnology, University of Bologna, Bologna, Italy.
Insights
Hematopoietic stem cell transplantation (HSCT) disrupts gut microbiota, impacting acute graft-versus-host disease (aGvHD). Specific pre-transplant gut bacteria signatures may predict and potentially prevent aGvHD, aiding HSCT success.
Area of Science:
- Microbiome research
- Immunology
- Hematopoietic stem cell transplantation
Background:
- Acute graft-versus-host disease (aGvHD) is a major complication following hematopoietic stem cell transplantation (HSCT).
- Understanding the gut microbiota's role in HSCT outcomes is crucial for improving patient care.
Purpose of the Study:
- To longitudinally analyze gut microbiota changes (phylogenetic and functional) in pediatric HSCT patients.
- To identify gut microbial signatures associated with the development of aGvHD.
- To explore the potential of pre-HSCT microbiota modulation for better HSCT outcomes.
Main Methods:
- Longitudinal study of pediatric patients undergoing HSCT.
- Analysis of gut microbiota composition and short-chain fatty acid production.
- Comparison of microbiota trajectories in patients with and without aGvHD, including pre-HSCT samples.
Main Results:
- HSCT causes temporary disruption and subsequent recovery of the gut microbial ecosystem over 100 days.
- Specific gut microbiota signatures before and after HSCT are linked to aGvHD onset.
- Patients not developing aGvHD had higher pre-HSCT levels of propionate-producing Bacteroidetes.
Conclusions:
- Gut microbiota structure and dynamics are critical factors for HSCT success.
- Pre-HSCT gut microbiota composition, particularly the abundance of certain beneficial bacteria, may predict aGvHD.
- Targeting the gut microbiota before HSCT offers a potential strategy to improve outcomes by promoting beneficial microbes with immunomodulatory functions.
Abstract:
Acute GvHD (aGvHD) is the main complication of hematopoietic SCT (HSCT) during the treatment of hematological disorders. We carried out the first longitudinal study to follow the gut microbiota trajectory, from both the phylogenetic and functional points of view, in pediatric patients undergoing HSCT. Gut microbiota trajectories and short-chain fatty acid production profiles were followed starting from before HSCT and through the 3-4 months after transplant in children developing and not developing aGvHD. According to our findings, HSCT procedures temporarily cause a structural and functional disruption of the gut microbial ecosystem, describing a trajectory of recovery during the following 100 days. The onset of aGvHD is associated with specific gut microbiota signatures both along the course of gut microbiota reconstruction immediately after transplant and, most interestingly, prior to HSCT. Indeed, in pre-HSCT samples, non-aGvHD patients showed higher abundances of propionate-producing Bacteroidetes, highly adaptable microbiome mutualists that showed to persist during the HSCT-induced ecosystem disruption. Our data indicate that structure and temporal dynamics of the gut microbial ecosystem can be a relevant factor for the success of HSCT and opens the perspective to the manipulation of the pre-HSCT gut microbiota configuration to favor mutualistic persisters with immunomodulatory properties in the gut.
Related Concept Videos
Development of Human Microbiota
Development of the Oral Microbiota
Introduction to the Human Microbiota
Anatomy of the Intestines
Small Intestines
The small intestine is an ~7 meter-long tube with an inner diameter of just 2.5 cm. Since most nutrients are absorbed here, the inner lining of the...
Microbiota of the Stomach and Small Intestine
Bone Marrow Sampling and Transplants
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...

